Cabaletta Bio (NASDAQ:CABA) Stock Price Expected to Rise, Guggenheim Analyst Says
Cabaletta Bio (NASDAQ:CABA – Get Free Report) had its price target raised by equities researchers at Guggenheim from $23.00 to $25.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Other research analysts have also recently issued reports about the company. Morgan Stanley decreased their […]
Cabaletta Bio (NASDAQ:CABA – Get Free Report) had its price target raised by equities researchers at Guggenheim from $23.00 to $25.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Other research analysts have also recently issued reports about the company. Morgan Stanley decreased their […]
